Dolby Laboratories (DLB) Receivables (2009 - 2026)

Dolby Laboratories has reported Receivables for 18 years, with the latest figure at $869.1 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 88.0% year-over-year to $869.1 million; the trailing twelve-month figure through Mar 2026 stood at $869.1 million (up 88.0% YoY), and the FY2025 full-year result was $511.9 million, down 25.46% from the prior year.
• Receivables for Q1 2026 stood at $869.1 million, up from $777.8 million in the prior quarter.
• The five-year high for Receivables was $869.1 million in Q1 2026, with the low at $401.3 million in Q1 2023.
• Historically, Receivables has averaged $581.7 million across 5 years, with a median of $532.9 million in 2022.
• Annual changes were most pronounced in 2022 — Receivables sank 36.22% — and 2026, when it soared 88.0%.
• Dolby Laboratories' Receivables stood at $617.4 million in 2022, then sank by 30.98% to $426.1 million in 2023, then soared by 83.3% to $781.1 million in 2024, then declined by 0.42% to $777.8 million in 2025, then grew by 11.74% to $869.1 million in 2026.
• The last three Receivables figures came in at $869.1 million (Q1 2026), $777.8 million (Q4 2025), and $511.9 million (Q3 2025), per Business Quant data.